Hypolipidemic effect and mechanism of ketoconazole without and with cholestyramine in familial hypercholesterolemia
Authors:
- Hannu VanhanenHVHannu Vanhanen
- Tatu A. MiettinenTMTatu A. Miettinen
- 31 January 1991
- journal article
- Published by Elsevier in Metabolism
- Vol. 40 (1) , 35-41
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Hormonal and Clinical Effects of Ketoconazole in Hirsute WomenThe Journal of Clinical Endocrinology & Metabolism, 1988
- Use of Ketoconazole in the Treatment of Cushing’s SyndromeThe Journal of Clinical Endocrinology & Metabolism, 1986
- Ketoconazole. Use in the treatment of ectopic adrenocorticotropic hormone production and Cushing's syndrome in small-cell lung cancerArchives of internal medicine (1960), 1985
- KETOCONAZOLE THERAPY IN CUSHING'S DISEASEThe Lancet, 1985
- KETOCONAZOLE THERAPY FOR ADVANCED PROSTATE CANCERThe Lancet, 1984
- Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes.Journal of Clinical Investigation, 1983
- Ketoconazole inhibits cortisol secretion of an adrenal adenoma in vivo and in vitroJournal of Molecular Medicine, 1983
- Ketoconazole blocks testosterone synthesisArchives of internal medicine (1960), 1982
- Ketoconazole Blocks Adrenal Steroid SynthesisAnnals of Internal Medicine, 1982
- Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugsPostgraduate Medical Journal, 1979